Format
Sort by

Send to

Choose Destination

Search results

Items: 2

  • Showing results for a modified search because your search retrieved no results.
1.

Real-world evidence of the effectiveness of ombitasvir-paritaprevir/r ± dasabuvir ± ribavirin in patients monoinfected with chronic hepatitis C or coinfected with human immunodeficiency virus-1 in Spain.

Manuel Sousa J, Vergara M, Pulido F, Sánchez Antolín G, Hijona L, Carnicer F, Rincón D, Salmerón J, Mateos-Muñoz B, Jou A, Polo-Lorduy B, Rubín Á, Escarda A, Aguilar P, Aldámiz-Echevarría T, García-Buey L, Carrión JA, Hernández-Guerra M, Chimeno-Hernández S, Espinosa N, Morillas RM, Andrade RJ, Delgado M, Gallego A, Magaz M, Moreno-Planas JM, Estébanez Á, Rico M, Menéndez F, Sampedro B, Morano L, Izquierdo S, Zozaya JM, Rodríguez M, Morán-Sánchez S, Lorente S, Martín-Granizo I, Von-Wichmann MÁ, Delgado M, Manzanares A.

PLoS One. 2019 Nov 12;14(11):e0225061. doi: 10.1371/journal.pone.0225061. eCollection 2019.

2.

Metabolic syndrome in Portugal: prevalence and implications for cardiovascular risk--results from the VALSIM Study.

Fiuza M, Cortez-Dias N, Martins S, Belo A; VALSIM study investigators.

Rev Port Cardiol. 2008 Dec;27(12):1495-529. English, Portuguese.

PMID:
19280993

Supplemental Content

Loading ...
Support Center